Tatsumi Kohei, Okano Teruo
Department of Physiology and Regenerative Medicine, Kindai University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-sayama, Osaka 589-8511 Japan.
Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan.
Curr Transplant Rep. 2017;4(3):184-192. doi: 10.1007/s40472-017-0156-7. Epub 2017 Aug 8.
We will review the recent developments of cell sheet technology as a feasible tissue engineering approach. Specifically, we will focus on the technological advancement for engineering functional liver tissue using cell sheet technology, and the associated therapeutic effect of cell sheets for liver diseases, highlighting hemophilia.
Cell-based therapies using hepatocytes have recently been explored as a new therapeutic modality for patients with many forms of liver disease. We have developed a cell sheet technology, which allows cells to be harvested in a monolithic layer format. We have succeeded in fabricating functional liver tissues in mice by stacking the cell sheets composed of primary hepatocytes. As a curative measure for hemophilia, we have also succeeded in treating hemophilia mice by transplanting of cells sheets composed of genetically modified autologous cells.
Tissue engineering using cell sheet technology provides the opportunity to create new therapeutic options for patients with various types of liver diseases.
我们将回顾细胞片技术作为一种可行的组织工程方法的最新进展。具体而言,我们将重点关注使用细胞片技术构建功能性肝组织的技术进步,以及细胞片对肝脏疾病的相关治疗效果,重点是血友病。
最近,使用肝细胞的细胞疗法已被探索作为多种肝病患者的一种新的治疗方式。我们开发了一种细胞片技术,该技术允许以单片层形式收获细胞。我们通过堆叠由原代肝细胞组成的细胞片,成功地在小鼠体内构建了功能性肝组织。作为血友病的一种治疗措施,我们还通过移植由基因改造的自体细胞组成的细胞片,成功地治疗了血友病小鼠。
使用细胞片技术的组织工程为各种肝病患者创造新的治疗选择提供了机会。